These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14087769)

  • 61. FURTHER STUDIES ON THE EFFECT OF DEXTRAN OF VARIOUS MOLECULAR WEIGHT ON THE COAGULATION MECHANISM.
    NILSSON IM; EIKEN O
    Thromb Diath Haemorrh; 1964 Apr; 11():38-50. PubMed ID: 14167114
    [No Abstract]   [Full Text] [Related]  

  • 62. COAGULATION FACTORS IN NEWBORN ANIMALS.
    HATHAWAY WE; HATHAWAY HS; BELHASEN LP
    J Lab Clin Med; 1964 May; 63():784-90. PubMed ID: 14158061
    [No Abstract]   [Full Text] [Related]  

  • 63. [Source of error in the supervision of postoperative anticoagulant therapy].
    Senst W; Nowak W; Wolf E
    Zentralbl Chir; 1967; 92(26a Pt 1):1432-4. PubMed ID: 5595671
    [No Abstract]   [Full Text] [Related]  

  • 64. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 65. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
    Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
    Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [STUDIES ON THE EFFECTS OF MITOMYCIN C AGAINST PATIENTS WITH MALIGNANT TUMORS, PARTICULARLY ON THE CHANGES OF COAGULATING FACTORS].
    YAMADA K
    Naika Hokan; 1964 May; 11():207-16. PubMed ID: 14180228
    [No Abstract]   [Full Text] [Related]  

  • 67. ANTICOAGULANT THERAPY; APPRAISAL OF ITS LABORATORY CONTROL.
    WARE AG; STERLING RE; STRAGNELL R
    Angiology; 1964 Jan; 15():11-6. PubMed ID: 14104834
    [No Abstract]   [Full Text] [Related]  

  • 68. FUNCTION OF AC-GLOBULIN AND LIPID IN BLOOD CLOTTING.
    SEEGERS WH; COLE ER; AOKI N
    Can J Biochem Physiol; 1963 Dec; 41():2441-61. PubMed ID: 14099702
    [No Abstract]   [Full Text] [Related]  

  • 69. Disseminated intravascular coagulation in shock.
    Hardaway RM ED
    Thromb Diath Haemorrh Suppl; 1969; 36():159-70. PubMed ID: 5385122
    [No Abstract]   [Full Text] [Related]  

  • 70. Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system.
    Julius U; Siegert G; Gromeier S
    Int J Artif Organs; 2000 Mar; 23(3):199-206. PubMed ID: 10795665
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Coagulation studies of patients taking low-dose heparin during and after major gynecologic surgery.
    Chung AF; Phillips LL; Levine G
    Am J Obstet Gynecol; 1979 Dec; 135(8):1025-9. PubMed ID: 517586
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC; Sanchez Avalos JC
    Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
    [No Abstract]   [Full Text] [Related]  

  • 73. Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin.
    Smith SA; Comp PC; Morrissey JH
    J Thromb Haemost; 2006 Jul; 4(7):1553-8. PubMed ID: 16839353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [THE BEHAVIOR OF DIFFERENT BLOOD COAGULATION FACTORS IN IRRADIATION OF GYNECOLOGICAL CARCINOMA WITH COBALT 60].
    GRAEBER W
    Strahlentherapie; 1964 May; 124():60-8. PubMed ID: 14216959
    [No Abstract]   [Full Text] [Related]  

  • 75. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
    Pechet L; Smith JA
    Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
    [No Abstract]   [Full Text] [Related]  

  • 76. [CHANGES IN THE ACTIVITY OF INDIVIDUAL FACTORS OF THE PROTHROMBIN COMPLEX IN AGING OF THE PLASMA].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():655-8. PubMed ID: 14241491
    [No Abstract]   [Full Text] [Related]  

  • 77. [SOME PROBLEMS OF THE ANTICOAGULANT TREATMENT OF DEEP VENOUS THROMBOSIS IN PREGNANCY].
    FORGACS J; NEMETH L
    Orv Hetil; 1964 Jun; 105():1162-5. PubMed ID: 14160767
    [No Abstract]   [Full Text] [Related]  

  • 78. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 80. [On the nature orf blood coagulation factors in the human urine].
    Kuznik BI; Kalikhman IaL
    Vopr Med Khim; 1968; 14(5):503-5. PubMed ID: 5727583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.